190 related articles for article (PubMed ID: 23440732)
41. Gene-gene interaction of glycogen synthase kinase 3-β and serotonin transporter on human antidepressant response to sleep deprivation.
Benedetti F; Dallaspezia S; Lorenzi C; Pirovano A; Radaelli D; Locatelli C; Poletti S; Colombo C; Smeraldi E
J Affect Disord; 2012 Feb; 136(3):514-9. PubMed ID: 22119086
[TBL] [Abstract][Full Text] [Related]
42. [Relationship between GSK-3 beta -50T/C and DBI +529A/T polymorphisms in Japanese alcoholics].
Kurihara K; Aoki J; Numajiri M; Ikeda K; Kawai A; Waga C; Yoshihara E; Murayama O; Iwahashi K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Oct; 45(5):430-6. PubMed ID: 21226341
[TBL] [Abstract][Full Text] [Related]
43. Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult.
Kozlovsky N; Nadri C; Agam G
Eur Neuropsychopharmacol; 2005 Jan; 15(1):1-11. PubMed ID: 15572268
[TBL] [Abstract][Full Text] [Related]
44. Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3.
Mishra R; Barthwal MK; Sondarva G; Rana B; Wong L; Chatterjee M; Woodgett JR; Rana A
J Biol Chem; 2007 Oct; 282(42):30393-405. PubMed ID: 17711861
[TBL] [Abstract][Full Text] [Related]
45. Glycogen synthase kinase-3β in patients with bipolar I disorder: results from a prospective study.
Jacoby AS; Munkholm K; Vinberg M; Joaquim HG; Talib LL; Gattaz WF; Kessing LV
Bipolar Disord; 2016 Jun; 18(4):334-41. PubMed ID: 27325150
[TBL] [Abstract][Full Text] [Related]
46. No association of GSK3beta gene (GSK3B) with Japanese schizophrenia.
Ikeda M; Iwata N; Suzuki T; Kitajima T; Yamanouchi Y; Kinoshita Y; Ozaki N
Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):90-2. PubMed ID: 15719395
[TBL] [Abstract][Full Text] [Related]
47. GSK3β genetic variability in patients with Multiple Sclerosis.
Galimberti D; Macmurray J; Scalabrini D; Fenoglio C; De Riz M; Comi C; Comings D; Cortini F; Villa C; Serpente M; Cantoni C; Ridolfi E; Fardipoor MH; Leone M; Monaco F; Bresolin N; Scarpini E
Neurosci Lett; 2011 Jun; 497(1):46-8. PubMed ID: 21527318
[TBL] [Abstract][Full Text] [Related]
48. [The relationship between glycogen synthase kinase - 3beta -1727A/T x -50T/C genetic polymorphisms and nicotine dependence].
Numajiri M; Nishizawa D; Ikeda K; Yoshihara E; Iwahashii K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2013 Oct; 48(5):293-9. PubMed ID: 24427901
[TBL] [Abstract][Full Text] [Related]
49. GSK-3 and the neurodevelopmental hypothesis of schizophrenia.
Kozlovsky N; Belmaker RH; Agam G
Eur Neuropsychopharmacol; 2002 Feb; 12(1):13-25. PubMed ID: 11788236
[TBL] [Abstract][Full Text] [Related]
50. A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depression.
Saus E; Soria V; Escaramís G; Crespo JM; Valero J; Gutiérrez-Zotes A; Martorell L; Vilella E; Menchón JM; Estivill X; Gratacòs M; Urretavizcaya M
Genes Brain Behav; 2010 Oct; 9(7):799-807. PubMed ID: 20618448
[TBL] [Abstract][Full Text] [Related]
51. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.
Pearce NJ; Arch JR; Clapham JC; Coghlan MP; Corcoran SL; Lister CA; Llano A; Moore GB; Murphy GJ; Smith SA; Taylor CM; Yates JW; Morrison AD; Harper AJ; Roxbee-Cox L; Abuin A; Wargent E; Holder JC
Metabolism; 2004 Oct; 53(10):1322-30. PubMed ID: 15375789
[TBL] [Abstract][Full Text] [Related]
52. Association between DAOA gene polymorphisms and the risk of schizophrenia, bipolar disorder and depressive disorder.
Tan J; Lin Y; Su L; Yan Y; Chen Q; Jiang H; Wei Q; Gu L
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():89-98. PubMed ID: 24447945
[TBL] [Abstract][Full Text] [Related]
53. GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients.
Nadri C; Dean B; Scarr E; Agam G
Schizophr Res; 2004 Dec; 71(2-3):377-82. PubMed ID: 15474909
[TBL] [Abstract][Full Text] [Related]
54. Brain Volume-Related Polymorphisms of the Glycogen Synthase Kinase-3β Gene and Their Effect on Antidepressant Treatment in Major Depressive Disorder.
Sunada N; Takekita Y; Nonen S; Wakeno M; Koshikawa Y; Ogata H; Kinoshita T; Kato M
Neuropsychobiology; 2019; 78(3):136-144. PubMed ID: 31189175
[TBL] [Abstract][Full Text] [Related]
55. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
Golpich M; Amini E; Hemmati F; Ibrahim NM; Rahmani B; Mohamed Z; Raymond AA; Dargahi L; Ghasemi R; Ahmadiani A
Pharmacol Res; 2015 Jul; 97():16-26. PubMed ID: 25829335
[TBL] [Abstract][Full Text] [Related]
56. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
[TBL] [Abstract][Full Text] [Related]
57. [Schizophrenia, neurodevelopment and glycogen synthase kinase-3].
Nadri C; Kozlovsky N; Agam G
Harefuah; 2003 Sep; 142(8-9):636-42, 644. PubMed ID: 14518171
[TBL] [Abstract][Full Text] [Related]
58. Association between glycogen synthase kinase-3beta gene polymorphisms and major depression and suicidal behavior in a Korean population.
Yoon HK; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):331-4. PubMed ID: 20015462
[TBL] [Abstract][Full Text] [Related]
59. Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients.
Kozlovsky N; Shanon-Weickert C; Tomaskovic-Crook E; Kleinman JE; Belmaker RH; Agam G
J Neural Transm (Vienna); 2004 Dec; 111(12):1583-92. PubMed ID: 15565492
[TBL] [Abstract][Full Text] [Related]
60. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in adult brain.
Takashima A
J Pharmacol Sci; 2009 Feb; 109(2):174-8. PubMed ID: 19179803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
